CLEVELAND - The German-based manufacturer of the popular blood thinner Pradaxa will pay $650 million to approximately 4000 patients to settle injury lawsuits.
Boehringer Ingelheim says it settled the claims to "avoid the distraction and uncertainty of lengthy litigation."
Most patients complaints related to claims the company failed to adequately warn patients about the risk of internal bleeding.
In February, an exclusive NewsChannel5 investigation revealed Pradaxa is the most complained about drug in the United States.
Our research found more complaints were filed with the FDA about Pradaxa than any other prescription drug in both 2011 and 2012.
Since it was approved by the FDA in 2010, Pradaxa has been blamed for 1,158 U.S. deaths and 12,494 serious injuries, according to Tom Moore, the senior scientist for drug safety and policy at the Institute for Safe Medication Practices. The ISMP is a non-profit organization that monitors FDA reports.
Pradaxa is used to treat atrial fibrillation, a heart condition that significantly increases the risk of stroke.
$4 million in school lunch food tossed each day
An exclusive 5 On Your Side investigation reveals millions of dollars worth of fresh fruits and vegetables are being thrown in the trash in…
Brushing with danger: Adding what to toothpaste?
A dental hygienist noticed something strange in her patients' mouths and now a major toothpaste manufacturer is making some changes.
Former warden calls escape "unacceptable"
A former Ohio prison warden is calling the prison escape by school shooter T.J. Lane "unacceptable" and suspects staff cutbacks…
TJ Lane prison has 'security concern'
INVESTIGATION: TJ Lane's escape was not first attempted at Lima prison.